| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Prevent infection | 58 | 34 | |
| Bladder problems | 57 | 15 | |
| Urinary tract infection | 28 | 18 | |
| Vesicoureteral reflux | 7 | 0 | |
| Frequent urination | 3 | 2 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Diarrhea | 3 | |
| Fatigue | 2 | |
| Stomach discomfort | 2 | |
| Abdominal cramps | 1 | |
| Abnormal urine color | 1 | |
| Chronic diarrhea | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 13 | |
| Mild | 16 | |
| None | 73 |
Member evaluations
Dawn Angel
evaluated on Sep 07, 2016
- Perceived effectiveness for neurogenic bladder: Major
- Side effects: Moderate
retardaggie
evaluated on Jul 14, 2011
- Perceived effectiveness for bladder problems: Major
- Side effects: None
retardaggie
evaluated on Nov 10, 2013
- Perceived effectiveness for Prevent infection: Moderate
- Side effects: None